| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000043284 |
| Receipt No. | R000047951 |
| Scientific Title | Evaluation of surgical outcome after endoscopic dacryocystorhinostomy |
| Date of disclosure of the study information | 2021/05/01 |
| Last modified on | 2021/02/09 (Ver. 1) |
| Basic information | ||
| Public title | Evaluation of surgical outcome after endoscopic dacryocystorhinostomy | |
| Acronym | Surgical outcome of endoscopic DCR | |
| Scientific Title | Evaluation of surgical outcome after endoscopic dacryocystorhinostomy | |
| Scientific Title:Acronym | Surgical outcome of endoscopic DCR | |
| Region |
|
|
| Condition | ||
| Condition | nasolacrimal duct obstruction,dacryocystitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to evaluate outcomes and prognostic factors of endoscopic DCR perfomed at Japanese Red Cross Osaka Hosopital and Hyogo Prefectural Amagasaki General Medical Center. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Anatomic patency based on lacrimal irrigation before surgery, 7 weeks after surgery, and 52 weeks after surgery. |
| Key secondary outcomes | 1.Assessment of change in tear meniscus height measured by anterior segment optical coherence tomography.
2.Quantitative assessment of improvement in subjective symptoms scored by tree-grade evaluation as follows: (1)complete resolution,(2)moderate epiphora,(3)no improvement These evaluations were performed before surgery, 7 weeks after surgery, and 52 weeks after surgery. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.The cases of nasolacrimal duct obstruction,acute and chronic dacryocystitis.
2.The case that have never undergone prior external and/or endoscopic DCR. |
|||
| Key exclusion criteria | 1.The case in which the part of obstruction is proximal to common canaliculus.
2.The case undergone endoscopic sinus surgery at the same time of endoscopic DCR. 3.The case of which consent can't be obtained from the patients. |
|||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japanese Red Cross Osaka Hosopital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 543-8555 | ||||||
| Address | 5-30 Fudegasakicho, Tennoji-ku,Osaka | ||||||
| TEL | 0667745111 | ||||||
| hospital@osaka-med.jrc.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japanese Red Cross Osaka Hosopital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 543-8555 | ||||||
| Address | 5-30 Fudegasakicho, Tennoji-ku,Osaka | ||||||
| TEL | 0667745111 | ||||||
| Homepage URL | https://www.osaka-med.jrc.or.jp/aboutus/information/ethics.html | ||||||
| hospital@osaka-med.jrc.or.jp | |||||||
| Sponsor | |
| Institute | Japanese Red Cross Osaka Hosopital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Hyougo Prefectural Amagasaki General Medical Center |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Japanese Red Cross Osaka Hosopital |
| Address | 5-30 Fudegasakicho, Tennoji-ku,Osaka |
| Tel | 0667745111 |
| hospital@osaka-med.jrc.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪赤十字病院、兵庫県立尼崎総合医療センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047951 |